Continuous Tableting Lines
At GEA we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product life-cycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Our solution for continuous tableting lines is ConsiGma®, a 6 sigma-inspired manufacturing platform, incorporating different technologies to produce oral solid dosage forms in a continuous, cost-efficient way:
- by collecting more information during R&D phase, in a short time with less product
- by excluding risky, time- and product consuming scale-up exercises
- by introducing online measurement and closed loop control targeting real-time release (6 sigma production)
- by incorporating flexible batch size (JIT production), reducing inventory
- by reducing the energy cost per tablet, reducing environmental impact.
Products
Mostrar 4 de 8
ConsiGma® Compact Feeder (CF) Test Rig
The ConsiGma® CF20 test rig is a standalone module that allows you to characterize the feeding behavior of your products during the early stages of R&D.
ConsiGma® Conductor
An indispensable part of the ConsiGma portfolio, the Conductor control system architecture ensures smooth operation and communication between the different elements of a pharmaceutical continuous manufacturing line
ConsiGma® Direct Compression with Linear Blending (DC-LB) Lines
A highly integrated solution for continuous linear blending and direct compression, the ConsiGma® DC-LB lines offer all the advantages of continuous manufacturing: supply chain agility, small footprint, controlled blending and compression and improved quality.
ConsiGma® Dosing and Blending (DB) Modules
Designed to achieve optimal blending results, the ConsiGma® DB modules facilitate the testing of dosing and blending operations and can be integrated with any continuous up- or downstream process.
Downloads
GEA Insights
Kytero 10 - los grandes cambios empiezan por lo pequeño
Con el GEA kytero 10, los investigadores y desarrolladores de las industrias biofarmacéutica, alimentaria y de nuevos alimentos tienen ahora a su disposición un potente acelerador de generación avanzada.
Una nueva receta para la indulgencia
¿Y si su chocolate favorito no necesitara granos de cacao y su café fuera de producción local? A medida que los trastornos climáticos, las subidas de precios y las preocupaciones éticas golpean a dos de nuestros caprichos más queridos, los científicos están reimaginando cómo los producimos: utilizando microbios, no monocultivos. El objetivo: preservar el sabor y las propiedades del café y el chocolate a la vez que se minimizan las emisiones de carbono y se mejora la resiliencia alimentaria.
En el menú: huevos más sostenibles
GEA ayuda a sus clientes a probar y escalar ovoproductos e ingredientes alternativos elaborados con fermentación de precisión.
